Koyama Eiji, Yamaguchi Masashi, Koyama Hiroshi, Teshima Shinichi, Saito Shigeru
Department of Cardiology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa 247-8533, Japan.
Department of Critical Care Medicine, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura 247-8533, Japan.
Eur Heart J Case Rep. 2025 May 26;9(6):ytaf262. doi: 10.1093/ehjcr/ytaf262. eCollection 2025 Jun.
Eosinophilic myocarditis is a rare and fatal form of inflammatory myocardial disease. It is frequently caused by a systemic disorder, which can remain undetected in up to one-third of patients. Eosinophilic myocarditis can have mild to fulminant clinical presentation.
We present a case of fulminant eosinophilic myocarditis in a 68-year-old woman. The patient was admitted for cardiogenic shock with electrocardiographic abnormalities and elevated troponin I levels. After an unremarkable coronary angiography, a myocardial biopsy was performed. Right-heart catheterization revealed low cardiac output and elevated mean pulmonary arterial wedge pressure. A lower pulmonary artery pulsatility index (0.63) indicated right ventricular dysfunction. Despite intensive treatment including dobutamine, the patient suffered a cardiac arrest triggered by sustained ventricular tachycardia. The patient was successfully resuscitated using veno-arterial extracorporeal membrane oxygenation and intra-aortic balloon pumping (IABP). IABP was upgraded to Impella CP at our hospital after the patient could not maintain her blood pressure. A biopsy showed eosinophilic myocarditis, despite a stagnant peripheral blood eosinophil count. Initiating methylprednisolone and immunoglobulin therapies improved left ventricular function. However, right ventricular function did not improve. Despite these treatments, the patient died 31 days after admission. Autopsy revealed minimal infiltration of inflammatory cells, suggesting the effectiveness of this medication. However, extensive necrotic changes were observed in the myocardium.
This case involved fulminant eosinophilic myocarditis with biventricular dysfunction treated with mechanical circulatory support and steroid therapy. Prompt steroid treatment before confirmation of biopsy results may improve the prognosis.
嗜酸性粒细胞性心肌炎是一种罕见且致命的炎症性心肌疾病。它常由全身性疾病引起,多达三分之一的患者可能未被发现。嗜酸性粒细胞性心肌炎的临床表现可从轻度到暴发性。
我们报告一例68岁女性的暴发性嗜酸性粒细胞性心肌炎病例。患者因心源性休克入院,伴有心电图异常和肌钙蛋白I水平升高。冠状动脉造影无异常后,进行了心肌活检。右心导管检查显示心输出量低,平均肺动脉楔压升高。较低的肺动脉搏动指数(0.63)表明右心室功能障碍。尽管进行了包括多巴酚丁胺在内的强化治疗,患者仍因持续性室性心动过速引发心脏骤停。使用静脉-动脉体外膜肺氧合和主动脉内球囊反搏(IABP)成功复苏。患者无法维持血压后,在我院将IABP升级为Impella CP。活检显示为嗜酸性粒细胞性心肌炎,尽管外周血嗜酸性粒细胞计数停滞。开始使用甲泼尼龙和免疫球蛋白治疗后左心室功能改善。然而,右心室功能未改善。尽管进行了这些治疗,患者在入院31天后死亡。尸检显示炎症细胞浸润极少,提示该药物有效。然而,心肌中观察到广泛的坏死改变。
本病例为伴有双心室功能障碍的暴发性嗜酸性粒细胞性心肌炎,采用机械循环支持和类固醇治疗。在活检结果确认前迅速进行类固醇治疗可能改善预后。